ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.
about
Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle propertiesHierarchically-Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor AccumulationDesign maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles.Nanogel Carrier Design for Targeted Drug DeliveryQuantitative comparison of tumor delivery for multiple targeted nanoparticles simultaneously by multiplex ICP-MSNanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model.Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure.Simultaneous quantification of tumor uptake for targeted and nontargeted liposomes and their encapsulated contents by ICPMS.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesEffect of ligand density, receptor density, and nanoparticle size on cell targetingBiodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticlesTherapeutic targeting in nanomedicine: the future lies in recombinant antibodies.Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy.Nanoparticle Biokinetics in Mice and Nonhuman Primates.Europium doping of superparamagnetic iron oxide nanoparticles enables their detection by fluorescence microscopy and for quantitative analytics.A fast and reproducible method to quantify magnetic nanoparticle biodistribution.
P2860
Q30744724-24655F4B-FDAC-4D30-A3E1-ED381E35910DQ30979863-C83AAC61-5791-4CEC-AD95-C34E26A787D6Q34603392-93CCFFBD-A00E-4C7B-9419-C68AAC3BFC42Q34609238-12DDB176-55C9-4E6F-A708-B21A755F9BB8Q35214069-B0D695FD-8251-48D3-8B32-FCDC72C2F7C5Q36058092-6C05148F-709B-4665-8822-814674EE9A52Q36088811-F19BDBEC-2AE0-4438-9E86-A99FA3CBD41DQ36238693-BB5E7B6B-CFBE-4457-A94D-01AA3103123FQ36289257-AE210656-1360-4840-8680-9138EDFB25E2Q36413263-3129E5A6-672E-4702-85BC-FA5539038F53Q36429106-84737A6B-8A90-48A9-963C-1A4206E5BD5EQ37518724-87C293BB-A506-4AEA-ACD4-1009D77234EEQ38658279-74F20409-4B3A-4BB3-8D7C-CF56092462B2Q42205877-EDD8D966-ADB4-45C5-A9F5-E8A4CB2EB1B9Q46310258-EB2A8AD7-E372-4347-8C54-96BE00CC31B3Q50193184-FAB6659F-AC55-4A3E-9B34-0D269CD938B9Q50226062-162E7D71-463F-43B5-A53A-43AB345E4CC5
P2860
ICP-MS analysis of lanthanide-doped nanoparticles as a non-radiative, multiplex approach to quantify biodistribution and blood clearance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@ast
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@en
type
label
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@ast
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@en
prefLabel
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@ast
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@en
P2093
P2860
P1433
P1476
ICP-MS analysis of lanthanide- ...... tribution and blood clearance.
@en
P2093
Ajlan Al Zaki
Andrew Tsourkas
Drew R Elias
Samuel H Crayton
Zhiliang Cheng
P2860
P304
P356
10.1016/J.BIOMATERIALS.2011.10.077
P577
2011-11-17T00:00:00Z